Healionics Corp.
This article was originally published in Start Up
Executive Summary
Device manufacturers looking to bolster the biocompatibility of their products can now turn to Healionics, a supplier of biomaterial scaffolds designed to improve the biointegration of percutaneous or fully implanted medical devices. The company's STAR technology is a synthetic, three-dimensional matrix, similar to a thin, porous sponge. Because this biomaterial has been precisely engineered with uniform pore sizes to the approximate size of a single cell, the company says that living tissue and new blood vessels actually grow and weave into these pores.
You may also be interested in...
Healionics Spins Out Ophthalmic Device Company In Europe
Companies offering broadly applicable biomaterials platforms often have an identify problem and with that, a funding problem. Seattle-based Healionics Corp. is solving that problem by creating clinically focused spin-outs that just happen to be in Europe where they can capture non-dilutive funding from regional governments. The company’s first spin-out, iSTAR Medical SA, is working on ophthalmic devices, specifically a suprachoroidal drainage shunt for glaucoma. In September, iSTAR was awarded a €3.6 million ($4.7 million) grant from Belgium’s Région Wallonne government.
Start-Up News
Noteworthy news from medtech start-ups, including MicroPhage's bacteriophage technology to identify drug-resistant bacteria, Healionics' technology for enhancing device biocompatability, and Gel Delivery Solutions' novel thermo-reversible drug delivery gel.
Start-Up News
Noteworthy news from medtech start-ups, including MicroPhage's bacteriophage technology to identify drug-resistant bacteria, Healionics' technology for enhancing device biocompatability, and Gel Delivery Solutions' novel thermo-reversible drug delivery gel.